Search www.satyamag.com

Satya has ceased publication. This website is maintained for informational purposes only.

To learn more about the upcoming Special Edition of Satya and Call for Submissions, click here.

back issues

 

March 2000
Xenotransplantation and the HIV Question: Two Views

 

At their meeting in Maryland on January 13 2000, the Food and Drug Administration (FDA) Xenotransplant Subcommittee, reviewed, among other things, proposed guidelines to indefinitely defer blood and plasma donations from xenotransplant recipients and their close contacts. Alix Fano, Director of the Campaign for Responsible Transplantation (CRT) comments:

"The mere fact that these guidelines are being proposed, demonstrates that xenotransplantation poses a threat to the public health. The FDA admits that xenotransplantation could spread known and unknown diseases to humans. It admits that, if these viruses got into the blood supply, it would be disastrous. And yet the new blood guidelines prove that FDA has failed to correct problems which jeopardized its ability to protect the nation’s blood supply in the 1980s [when people received HIV-tainted blood and blood products].

"In the CRT’s view, the FDA’s xenotransplant policy is based on containment, rather then prevention of infectious diseases. Xenotransplantation is causing a mountain of problems and extra work for numerous branches and agencies of the federal government. We are concerned that the FDA has already failed to provide oversight for human tissues infected with HIV; it was cited for weak oversight of tracking and recall systems for defective medical devices and medical implants; and in 1996, it approved the use of a bioengineered plasma product that transmitted hepatitis A to hemophiliacs...If the FDA was truly interested in protecting the blood supply and the public health, it would ban xenotransplantation immediately."

The CRT is an international coalition of 80 public interest groups opposing animal-to-human organ, cell and tissue transplants (xenotransplants). Visit them at www.crt-online.org

Jeff Getty, an AIDS patient and ACT UP/Golden Gate activist, received an experimental transplant on December 14, 1995 in San Francisco. Getty, who was then in his mid 1930s and moving into advanced AIDS, received an injection of baboon bone marrow in the hope that it would colonize his own bones and eventually create a population of immune cells in his system that would not be not affected by HIV.

At first, Getty’s health improved, although this could have been a temporary consequence of other treatments he received at the same time. "I had been at death’s door," he said, "But I got one pretty good year out of it." He has kept his weight up with the help of human growth hormone and anabolic steroids, and has taken several experimental medications to slow the virus’ attack.

Some authorities fear that wide use of animal organs could introduce new viruses or other microbes into people, possibly spawning epidemics against which modern medicine and natural human immunology would have few defenses. In addition, xenotransplant survivors may unwittingly introduce such viruses to the blood supply by donating their blood.

Getty describes as ‘unethical’ the situation that someone may have to die because they cannot receive a xenotransplant for fear of introducing an animal disease into the human population. Getty, who continues to live with AIDS, said that his experience turned him into a crusader for animal-to-human transplants. His goal has been to break down what he calls the psychological and irrational fears on the part of many people. Satya spoke with Getty in February, and he confirmed his continuing support of xenotransplantation, and added that he is living proof that it is safe. He said "I believe it’s human centrism—the idea that we are superior to all other species—that makes people think we are corrupting ourselves by receiving transplants from other animals." Since people with HIV/AIDS are normally not allowed to receive human organ transplants, Getty believes that the inclusion of animal organs in the supply would alleviate this shortage.

 


© STEALTH TECHNOLOGIES INC.
All contents are copyrighted. Click here to learn about reprinting text or images that appear on this site.